questions and answers latest edition (all
graded A+)
Key |Points |for |Combination |Therapy |- |ANSOncology |Nurses |must |consider
Consider |the |potential |toxicity |related |to |each |drug.
Understand |the |monitoring |guidelines |for |each |drug.
Have |knowledge |of |clinically |significant |signs |and |symptoms
ONS |Evidence-Based |Practice |Resources |- |ANSEvidence-based |practice |can |have |positive |
effects, |such |as:
Improved |patient |outcomes
Increased |nurse |satisfaction
Potential |cost |savings
Risk |Factors |For |Colon |Cancer |- |ANSIncreased |age |is |a |risk |factor |for |developing |colorectal |
cancer. |The |chance |of |developing |colorectal |cancer |increases |markedly |after |age |50. |Roughly |9
|out |of |10 |people |diagnosed |with |colorectal |cancer |are |at |least |50 |years |old. |Smoking, |alcohol |
intake, |and |a |personal |history |of |polyps |are |all |things |that |increase |risk. |Other |risk |factors |for |
the |development |of |colorectal |cancer |include: |
Racial |and |ethnic |backgrounds |(African |Americans |and |Jews |of |Eastern |European |descent |
[Ashkenazi |Jews] |have |highest |incidence)
Diet |high |in |red |and |processed |meats
Physical |inactivity, |obesity
, Type |2 |diabetes
Family |history |of |colon |cancer |or |inflammatory |bowel |disease
Inherited |familial |syndromes |(FAP, |HNPCC)
Patient |Education |on |Chemotherapy |- |ANSPatients |are |provided |with |verbal |and |written |or |
electronic |information |as |part |of |an |education |process |before |the |first |administration |of |
treatment |of |each |treatment |plan. |The |content |of |this |educational |material |will |be |
documented. |Educational |information |includes |the |following |at |a |minimum:
Patient's |diagnosis
Goals |of |treatment; |that |is, |cure |disease, |prolong |life, |or |reduce |symptoms
Planned |duration |of |treatment, |schedule |of |treatment |administration, |drug |names |and |
supportive |medications, |drug-drug |and |drug-food |interactions, |and |plan |for |missed |doses
Potential |long-term |and |short-term |adverse |effects |of |therapy, |including |infertility |risks |for |
appropriate |patients
Symptoms |or |adverse |effects |that |require |the |patient |to |contact |the |healthcare |setting |or |to |
seek |immediate |attention
Symptoms |or |events |that |require |immediate |discontinuation |of |oral |or |other |self-administered
|treatments
Procedures |for |handling |medications |in |the |home, |including |storage, |safe |handling, |and |
management |of |unused |medication
Procedures |for |handling |body |secretions |and |waste |in |the |home
Follow-up |plans, |including |laboratory |and |provider |visits
Contact |information |for |the |healthcare |setting, |with |availability |and |instructions |on |when |and |
who |to |call
The |missed |appointment |policy |of |the |healthcare |setting |and |expectations |for |rescheduling |or |
cancelling
Education |includes |family, |caregivers, |or |others |based |on |the |patient's |ability |to |assume |
responsibility |for |managing |therapy. |Educational |activities |will |be |performed |based |on |the |
patient's |learning |needs, |abilities, |preferences, |and |readiness |to |learn.